AACR Announces Revised News Release Embargo Policy
PHILADELPHIA — The American Association for Cancer Research has updated its embargo sanctions policy. This revised policy affects all meetings and journals promoted by the AACR.
In sum, the AACR supports quality scientific journalism and recognizes that comprehensive stories take time to prepare carefully. Toward that end, the AACR Communications Department often releases material early, under embargo, to credentialed journalists. This process requires trust and responsibility on the part of both parties. The revised embargo policy recognizes that journalists and other media professionals occasionally make honest mistakes; these mistakes should not permanently damage the relationship between the association and the media.
Therefore, each embargo break by a journalist or outlet will be investigated by the AACR Communications Department. If the break is determined to be accidental, the outlet will take internal steps to make sure its processes are corrected. After assurances are made, both verbally and in writing, that these steps have been taken, the AACR will maintain the press credentials of the media outlet.
However, repeat offenders may face sanctions at the discretion of the AACR Communications Department, which potentially include removal from AACR mailing lists, dismissal from AACR meetings and the possible removal of the ability to cover other AACR events.
Read the complete, revised AACR embargo policy.
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 laboratory, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards to young investigators, and it also funds cutting-edge research projects conducted by senior researchers. The AACR has numerous fruitful collaborations with organizations and foundations in the U.S. and abroad, and functions as the Scientific Partner of Stand Up To Cancer, a charitable initiative that supports groundbreaking research aimed at getting new cancer treatments to patients in an accelerated time frame. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care, and Educational Workshops are held for the training of young cancer investigators. The AACR publishes seven major peer-reviewed journals: Cancer Discovery; Cancer Research; Clinical Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Prevention Research. In 2010, AACR journals received 20 percent of the total number of citations given to oncology journals. The AACR also publishes Cancer Today, a magazine for cancer patients, survivors and their caregivers, which provides practical knowledge and new hope for cancer survivors. A major goal of the AACR is to educate the general public and policymakers about the value of cancer research in improving public health, the vital importance of increases in sustained funding for cancer research and biomedical science, and the need for national policies that foster innovation and the acceleration of progress against the 200 diseases we call cancer.